0001104659-18-048859.txt : 20180801
0001104659-18-048859.hdr.sgml : 20180801
20180801192101
ACCESSION NUMBER: 0001104659-18-048859
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180730
FILED AS OF DATE: 20180801
DATE AS OF CHANGE: 20180801
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LITTLECHILD JOHN W
CENTRAL INDEX KEY: 0001013469
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37990
FILM NUMBER: 18986191
MAIL ADDRESS:
STREET 1: 55 CAMBRIDGE PARKWAY
STREET 2: SUITE 301
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LEAP THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001509745
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 274412575
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 47 THORNDIKE STREET
STREET 2: SUITE B1-1
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617 252 4343
MAIL ADDRESS:
STREET 1: 47 THORNDIKE STREET
STREET 2: SUITE B1-1
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Dekkun Corp
DATE OF NAME CHANGE: 20110107
4
1
a4.xml
4
X0306
4
2018-07-30
0
0001509745
LEAP THERAPEUTICS, INC.
LPTX
0001013469
LITTLECHILD JOHN W
C/O LEAP THERAPEUTICS, INC.
47 THORNDIKE STREET SUITE B1-1
CAMBRIDGE
MA
02141
1
0
1
0
Warrant (Right to Buy)
6.085
2018-07-30
4
J
0
2137
0
A
2017-11-14
2024-11-14
Common Stock
2137
2137
D
Pro rata distribution from HealthCare Ventures IX, L.P., of which the reporting person is a limited partner. The reporting person is also a Managing Director of HealthCare Partners VIII, LLC, which is General Partner of HealthCare Partners VIII, L.P., which is the General Partner of HealthCare Ventures VIII, L.P. ("HCV VIII"). HCV VIII continues to hold 2,618,406 shares of common stock, representing 17.8% of the outstanding shares of common stock.
/s/ Douglas E. Onsi as attorney-in-fact for John W. Littlechild
2018-08-01